Terms: = Prostate cancer AND Ki-67 AND Treatment
214 results:
1. The Predictive Role of Serum Lipid Levels, p53 and ki-67, According to Molecular Subtypes in Breast cancer: A Randomized Clinical Study.
Faur IF; Dobrescu A; Clim IA; Pasca P; Prodan-Barbulescu C; Tarta C; Neamtu AA; Brebu D; Neamtu C; Rosu M; Duta C; Clim A; Lazar G; Totolici B
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612725
[TBL] [Abstract] [Full Text] [Related]
2. Microwave hyperthermia enhances radiosensitization by decreasing DNA repair efficiency and inducing oxidative stress in PC3 prostatic adenocarcinoma cells.
Wu Y; Liu P; Chen W; Bai S; Chen S; Chen J; Xu X; Xia J; Wu Y; Lai J; Sun C; Lao Z; Wan X; Wu Z
Int J Hyperthermia; 2024; 41(1):2335201. PubMed ID: 38583875
[TBL] [Abstract] [Full Text] [Related]
3. Curcumin inhibits prostate cancer by upregulating miR-483-3p and inhibiting UBE2C.
Li W; Wang F; Wang X; Xu W; Liu F; Hu R; Li S
J Biochem Mol Toxicol; 2024 Feb; 38(2):e23645. PubMed ID: 38348716
[TBL] [Abstract] [Full Text] [Related]
4. Carvedilol induces pyroptosis through NLRP3-caspase1-ASC inflammasome by nuclear migration of NF-κB in prostate cancer models.
Zeng Y; Li MX; Wu SQ; Xu C
Mol Biol Rep; 2024 Jan; 51(1):201. PubMed ID: 38270665
[TBL] [Abstract] [Full Text] [Related]
5. 68 Ga-PSMA-11 PET/CT Imaging in Brain Gliomas and Its Correlation With Clinicopathological Prognostic Parameters.
Verma P; Singh BK; Sudhan MD; Singh RK; Bagul SD; Chandak AR; Soni BK; Shelly D; Basu S
Clin Nucl Med; 2023 Dec; 48(12):e559-e563. PubMed ID: 37883060
[TBL] [Abstract] [Full Text] [Related]
6. Combined Dextran-Graft-Polyacrylamide/Zinc Oxide Nanocarrier for Effective Anticancer Therapy in vitro.
Chumachenko V; Virych P; Nie G; Virych P; Yeshchenko O; Khort P; Tkachenko A; Prokopiuk V; Lukianova N; Zadvornyi T; Rawiso M; Ding L; Kutsevol N
Int J Nanomedicine; 2023; 18():4821-4838. PubMed ID: 37662686
[TBL] [Abstract] [Full Text] [Related]
7. Histological findings in resected leiomyomas following MR-HIFU treatment, single-institution data from seven patients with unfavorable focal therapy.
Viitala A; Gabriel M; Joronen K; Komar G; Perheentupa A; Sainio T; Huvila J; Pikander P; Taimen P; Blanco Sequeiros R
Int J Hyperthermia; 2023; 40(1):2234666. PubMed ID: 37487574
[TBL] [Abstract] [Full Text] [Related]
8. Combination of Lycopene and Curcumin Synergistically Alleviates Testosterone-Propionate-Induced Benign Prostatic Hyperplasia in Sprague Dawley Rats via Modulating Inflammation and Proliferation.
Wang S; He W; Li W; Zhou JR; Du Z
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446563
[TBL] [Abstract] [Full Text] [Related]
9. Proapoptotic effect of nonthermal pulsed ultrasound on prostate cancer cells in a nude mouse model.
Maeda K; Shigemura K; Hayashi F; Kan Y; Hiraoka A; Yamaguchi A; Ueda M; Yang YM; Maeshige N; Ooya T; Nakano Y; Fujisawa M
Prostate; 2023 Sep; 83(12):1217-1226. PubMed ID: 37221965
[TBL] [Abstract] [Full Text] [Related]
10. Selective ablation of TRA-1-60
White JM; Ramos N; Saliganan AD; Chung JY; Bell M; Lindquist J; Conner K; Wiesend WN; Schopperle M; Patrick SM; Kim S; Heath EI; Escorcia FE; Viola NT
Theranostics; 2023; 13(7):2057-2071. PubMed ID: 37153742
[No Abstract] [Full Text] [Related]
11. Ketorolac modulates Rac-1/HIF-1α/DDX3/β-catenin signalling via a tumor suppressor prostate apoptosis response-4 (Par-4) in renal cell carcinoma.
Sonawane V; Ghosalkar J; Achrekar S; Joshi K
Sci Rep; 2023 Apr; 13(1):5659. PubMed ID: 37024613
[TBL] [Abstract] [Full Text] [Related]
12. The ethanol extract of Cyperus exaltatus var. iwasakii exhibits cell cycle dysregulation, ERK1/2/p38 MAPK/AKT phosphorylation, and reduced MMP-9-mediated metastatic capacity in prostate cancer models in vitro and in vivo.
Kim H; Hwang B; Cho S; Kim WJ; Myung SC; Choi YH; Kim WJ; Lee S; Moon SK
Phytomedicine; 2023 Jun; 114():154794. PubMed ID: 37011419
[TBL] [Abstract] [Full Text] [Related]
13. Senescent Tumor Cells Are Frequently Present at the Invasion Front: Implications for Improving Disease Control in Patients with Locally Advanced prostate cancer.
Schwarz S; Nientiedt C; Prigge ES; Kaczorowski A; Geisler C; Lucena Porcel C; von Knebel Doeberitz M; Hohenfellner M; Duensing S
Pathobiology; 2023; 90(5):312-321. PubMed ID: 37004506
[TBL] [Abstract] [Full Text] [Related]
14. [Exosomes derived from mesenchymal stem cells loaded with annexin A2 reduce the polarization of M2 macrophages to inhibit the growth of prostate cancer cells in nude mice].
Tian Y; Guo X; Cheng J; Wang P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Feb; 39(2):109-116. PubMed ID: 36872428
[TBL] [Abstract] [Full Text] [Related]
15. Effects of Mesenchymal Stem Cells treatment on Radiation-Induced Proctitis in Rats.
Kim WH; Yoo JH; Yoo IK; Kwon CI; Hong SP
Yonsei Med J; 2023 Mar; 64(3):167-174. PubMed ID: 36825342
[TBL] [Abstract] [Full Text] [Related]
16. The roles of 68 Ga-PSMA PET/CT and 18 F-FDG PET/CT imaging in patients with triple-negative breast cancer and the association of tissue PSMA and claudin 1, 4, and 7 levels with PET findings.
Arslan E; Ergül N; Beyhan E; Erol Fenercioglu Ö; Sahin R; Cin M; Battal Havare S; Can Trabulus FD; Mermut Ö; Akbas S; Fikret Çermik T
Nucl Med Commun; 2023 Apr; 44(4):284-290. PubMed ID: 36756767
[TBL] [Abstract] [Full Text] [Related]
17. The effect of a phytoestrogen intervention and impact of genetic factors on tumor proliferation markers among Swedish patients with prostate cancer: study protocol for the randomized controlled PRODICA trial.
Ahlin R; Nybacka S; Josefsson A; Stranne J; Steineck G; Hedelin M
Trials; 2022 Dec; 23(1):1041. PubMed ID: 36544211
[TBL] [Abstract] [Full Text] [Related]
18. Clinical Significance of High Expression of tRF-Glu-TTC-2 in prostate Carcinoma and its Effect on Growth.
Wang L; Liu Y; Yan W; Huang C; Ding Z; Yang J; Jiang S; Sun L
Am J Mens Health; 2022; 16(6):15579883221135970. PubMed ID: 36377736
[TBL] [Abstract] [Full Text] [Related]
19. EFFECTS OF DEXTRAN-GRAFT-POLYACRYLAMIDE/ZnO NANOPARTICLES ON prostate cancer CELL LINES IN VITRO.
Virych PA; Zadvorniy TV; Borikun TV; Lykhova OO; Chumachenko VA; Virych PA; Pavlenko VA; Kutsevol NV; Lukianova NY
Exp Oncol; 2022 Nov; 44(3):217-221. PubMed ID: 36325704
[TBL] [Abstract] [Full Text] [Related]
20. Copper(II) Complex Containing 4-Fluorophenoxyacetic Acid Hydrazide and 1,10-Phenanthroline: A prostate cancer Cell-Selective and Low-Toxic Copper(II) Compound.
Bontempo NJS; Paixão DA; Lima PMAP; Barros DCT; Borges DS; Orsolin PC; Martins IC; Machado PHA; Lino RC; Souza TR; Ramos LMS; Teixeira SC; Siqueira RP; Goulart Filho LR; Guerra W; Oliveira Júnior RJ; Araújo TG
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296690
[TBL] [Abstract] [Full Text] [Related]
[Next]
